Litchman Manuel MD 4
4 · MUSTANG BIO, INC. · Filed Sep 24, 2021
Insider Transaction Report
Form 4
Litchman Manuel MD
DirectorPresident, CEO and Interim CFO
Transactions
- Award
COMMON STOCK
2021-08-31$2.58/sh+2,746$7,085→ 962,987 total
Footnotes (2)
- [F1]These shares were acquired under the Mustang Bio, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on March 1, 2021 and ending on August 31, 2021 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on August 31, 2021 (the purchase date of the offering period).
- [F2]Includes restricted stock units, which vest over various time periods.